Clin2
NCT06546111Possibly a fitRecruiting

Diosmin and hesperidin for H. pylori infection

Helicobacter Pylori Infection

Part of Digestive system, Infections clinical trials.

This trial tests whether a combination of two natural plant compounds, diosmin and hesperidin, can safely and effectively treat Helicobacter pylori (H. pylori) infection in people who have not been treated for it before. The goal is to see if this therapy offers a new option for clearing the bacteria.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
46 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You must have a confirmed H. pylori infection from a stool test.
  • You have never received treatment for H. pylori before.
  • You are between 18 and 75 years old.
  • You are able to understand and follow the study procedures.
  • You are not pregnant or breastfeeding, and are not taking certain medications like blood thinners, anti-seizure drugs, muscle relaxants, NSAIDs, or anti-inflammatory drugs.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06929962Recruiting· Phase 4
VA dual sequential therapy for H. pylori gastritis

This trial tests a new two-step antibiotic treatment for adults with chronic gastritis caused by H. pylori bacteria. If you have not been treated for H. pylori before and are between 18 and 70, you may be able to join.

Nanjing, Jiangsu
NCT07729293Not yet recruiting
A new add-on treatment for H. pylori infection

This study tests a new treatment called Pylori Duo, used along with standard care, to help get rid of H. pylori bacteria in the stomach and stop it from coming back. It may be a good option if you are newly diagnosed and haven't been treated before.

Don Benito, Badajoz
NCT07827170Not yet recruiting
Probiotics with standard H. pylori treatment

This study tests whether adding a probiotic (a healthy bacteria supplement) to the standard four-drug treatment for H. pylori infection helps get rid of the bacteria better and with fewer side effects. It may help make your treatment more effective and easier to tolerate.

Hanoi
NCT07624422Not yet recruiting· Phase 4
Helicobacter pylori infection treatment study

This study tests a new antibiotic combination to treat stomach infections caused by H. pylori bacteria. It may help clear the infection and reduce stomach problems.

Damascus
NCT07139366Recruiting· Phase 4
Probiotic plus bismuth combo for stubborn H. pylori

This study tests a combination of a probiotic (Saccharomyces boulardii) plus a standard bismuth-based four-drug treatment for people whose H. pylori infection has not been cured by previous treatments. It aims to see if adding the probiotic helps the treatment work better and cause fewer side effects.

Xi'an, Shaanxi
NCT06200779Not yet recruiting· Phase 4
Personalized versus standard treatment for H. pylori infection

This study is testing whether giving H. pylori treatment based on the specific bacteria found in your stomach works better than the standard one-size-fits-all approach. If you are already getting an endoscopy with a biopsy, this trial could help find the most effective medication for your infection.

Porto, Porto District

Hear when a new Helicobacter Pylori Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.